News & Articles
Selected Filters:
BostonGene RNA transcriptome profiling reveals new ADC targets in advanced solid tumours
Prospective UT MD Anderson study shows RNA analysis expands on treatment options beyond DNA testing
Thermo Fisher Scientific’s Oncomine Dx Target Test receives FDA approval
Test will serve as a companion diagnostic for Bayer’s HYRNUO™ (sevabertinib) to identify patients with non-small cell lung cancer eligible for HER2-targeted therapy
Teaching AI to see: How the next era of digital pathology is being driven by curated biospecimen data
In this guest editorial, Daryl Waggott, Head of Data Products, BioIVT, highlights the critical role of ethically sourced, clinically linked biospecimen datasets in advancing computational tumor biology.
Stilla and Promega announce co-marketing agreement to offer complete digital PCR workflow solution
Companies will showcase combined solution at American Association for Cancer Research (AACR) Annual Meeting 2022
SCIEX announces the development of its icIEF-MS technology
New icIEF technology provides a unique and powerful analysis method to address key analytical challenges
Thermo Fisher Scientific expands hematology oncology NGS portfolio
Immune repertoire assays offer high detection rates of malignant clones, empowering researchers to better assess blood cancers
6 Trending Cancer Research Videos on The Scientists' Channel
Connect with scientists around the world and discover the latest innovations in cancer research with videos from The Scientists' Channel
QIAGEN Reaches Milestone with Portfolio of Master Collaboration Agreements for Pharma Companion Diagnostics
Record number of new projects involves start of new master collaboration with Array BioPharma



















